Karunakaran Kalesh

8PUBLICATIONS
9CO-AUTHORS
Characterisation of biological macromoleculesPharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2025
Profiling Serine Hydrolases in the Leishmania Host-Pathogen Interactome Using Cell-Permeable Activity-Based Fluorophosphonate Probes.

Jaime A Isern, Exequiel O J Porta, Karunakaran Kalesh

|Nov 27, 2024
Nucleoside Analogues for Chagas Disease and Leishmaniasis Therapy: Current Status and Future Perspectives.

Emmanuel Awucha Nwoke, Silvester Lowe, Fawaz Aldabbagh

|Oct 25, 2024
BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment.

John G Mina, Anutthaman Parthasarathy, Exequiel O Porta

|Oct 31, 2023
Inhibition of HSP90 distinctively modulates the global phosphoproteome of Leishmania mexicana developmental stages.

Exequiel O Porta, Liqian Gao, Paul W Denny

|Feb 09, 2022
Transcriptome-Wide Identification of Coding and Noncoding RNA-Binding Proteins Defines the Comprehensive RNA Interactome of Leishmania mexicana.

Karunakaran Kalesh, Wenbin Wei, Brian S Mantilla

|May 12, 2021
Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana.

Karunakaran Kalesh, Sandeep Sundriyal, Hirunika Perera

Pageof 2

Frequent Collaborators

2 joint publications

Anutthaman Parthasarathy

2 joint publications

Exequiel O Porta

2 joint publications

Paul W Denny

1 joint publications

John G Mina